Showing results (381-390 of 413) with videos related to

Sort By:
Pageof 42
Oncogene|October 24, 2017
FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasisM S Chattaragada, C Riganti, M Sassoe, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 4, 2012
Efficacy and safety of risedronate 150-mg once a month in the treatment of postmenopausal osteoporosis: 2-year dataM R McClung, J R Zanchetta, A Racewicz, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 30, 2011
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosisJ-Y Reginster, J-M Kaufman, S Goemaere, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 29, 2014
Denosumab significantly increases bone mineral density and reduces bone turnover compared with monthly oral ibandronate and risedronate in postmenopausal women who remained at higher risk for fracture despite previous suboptimal treatment with an oral bisphosphonateJ P Brown, C Roux, P R Ho, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|January 15, 2011
High throughput analysis of grape genetic diversity as a tool for germplasm collection managementV Laucou, T Lacombe, F Dechesne, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 5, 2002
Two-year results of once-weekly administration of alendronate 70 mg for the treatment of postmenopausal osteoporosisR Rizzoli, S L Greenspan, G Bone, et al.
Pageof 42